⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

Official Title: A Phase 1b/2a Three-Part Open-Label Multicenter Study to Evaluate the Safety and Efficacy of LY2880070 as Monotherapy and in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer

Study ID: NCT02632448

Study Description

Brief Summary: The main purpose of this 3-part study is to evaluate the safety and efficacy of the study drug known as LY2880070 in participants with advanced or metastatic solid tumors.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Karmanos Cancer Institute, Detroit, Michigan, United States

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Cross Cancer Institute, Edmonton, Alberta, Canada

BC Cancer Agency, Vancouver, British Columbia, Canada

Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

University Health Network - Princess Margaret Hospital, Toronto, Ontario, Canada

Jewish General Hospital, Montreal, Quebec, Canada

McGill University Health Centre, Montreal, Quebec, Canada

Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada

General Hospital Zadar, Zadar, , Croatia

University Hospital Centre Zagreb, Zagreb, , Croatia

Centrum Onkologii im. prof. F. Łukaszczyka, Bydgoszcz, , Poland

Uniwersyteckie Centrum Kliniczne Osrodek Badan Klinicznych Wczesnych Faz, Gdańsk, , Poland

Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o. o., Kraków, , Poland

Szpital Specjalistyczny im. L. Rydygiera w Krakowie sp. z o. o., Kraków, , Poland

Contact Details

Name: Email: Darcy.Vincett@ozmosisresearch.ca

Affiliation: Esperas Pharma Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: